Patents by Inventor Douglas K. Tadaki

Douglas K. Tadaki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allograft tolerance induction
    Patent number: 9457052
    Abstract: A method inducing chimerism and allograft tolerance by co-infusion of stem/progenitor-like cells and donor cells, wherein the donor cells can be bone marrow cells. The method also comprises the conditioning comprising depletion of CD4+ and CD8+ T-cells and administration of low doses of anti-neoplastic drugs. The inventive method comprises an aspect wherein allograft tolerance is induced without systemically suppressing the immune system.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: October 4, 2016
    Assignee: The United States of America as Represented by the Secretary of the Navy
    Inventors: Thomas A. Davis, Khairul Anam, Eric A. Elster, Douglas K. Tadaki
  • Allograft tolerance induction
    Publication number: 20160256489
    Abstract: A method inducing chimerism and allograft tolerance by co-infusion of stein/progenitor-like cells and donor cells, wherein the donor cells can be bone marrow cells. The method also comprises the conditioning comprising depletion of CD4+ and CD8+ T-cells and administration of low doses of anti-neoplastic drugs. The inventive method comprises an aspect wherein allograft tolerance is induced without systemically suppressing the immune system.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 8, 2016
    Inventors: Thomas A. Davis, Khairul Anam, Eric A. Elster, Douglas K. Tadaki
  • Allograft tolerance induction
    Publication number: 20150258144
    Abstract: A method inducing chimerism and allograft tolerance by co-infusion of stein/progenitor-like cells and donor cells, wherein the donor cells can be bone marrow cells. The method also comprises the conditioning comprising depletion of CD4+ and CD8+ T-cells and administration of low doses of anti-neoplastic drugs. The inventive method comprises an aspect wherein allograft tolerance is induced without systemically suppressing the immune system.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 17, 2015
    Inventors: Thomas A. Davis, Khairul Anam, Eric A. Elster, Douglas K. Tadaki